{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T15:35:46Z","timestamp":1770219346951,"version":"3.49.0"},"reference-count":27,"publisher":"American Veterinary Medical Association (AVMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ajvr"],"published-print":{"date-parts":[[2008,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n<jats:p><jats:bold>Objective<\/jats:bold>\u2014To determine the diuretic effects and changes in plasma aldosterone concentration (PAC) following oral administration of a single dose of furosemide or azosemide in healthy dogs.<\/jats:p>\n<jats:p><jats:bold>Animals<\/jats:bold>\u20148 mixed-breed dogs.<\/jats:p>\n<jats:p><jats:bold>Procedures<\/jats:bold>\u2014A single dose of furosemide (2 mg\/kg), azosemide (1, 5, or 10 mg\/kg), or placebo (bifidobacterium [1 mg\/kg]) was administered orally (in random order at 7-day intervals) to each dog (5 treatments\/dog). Urine and blood samples were collected before (2 hours after evacuation of the urinary bladder; baseline) and at intervals for 24 hours after drug treatment to assess urine volume and plasma and urine biochemical variables.<\/jats:p>\n<jats:p><jats:bold>Results<\/jats:bold>\u2014Compared with baseline values, treatment with furosemide and azosemide (5 and 10 mg\/kg) increased urine output for 1 to 2 hours and 2 to 4 hours, respectively. The 24-hour urine volume and urinary sodium excretion were significantly increased following furosemide and azosemide (5 and 10 mg\/kg) treatments, compared with effects of pla-cebo; these increases were dose dependent for azosemide, and increases were similar for furosemide and the 5 mg\/kg dose of azosemide. Compared with other treatments, 24-hour urinary potassium excretion was significantly increased with azosemide at 10 mg\/kg. Azosemide (5 and 10 mg\/kg) significantly increased plasma total protein concentration and decreased plasma potassium concentration, compared with baseline values. Compared with the effect of placebo, PAC was significantly increased by furosemide and the 10 mg\/kg dose of azosemide.<\/jats:p>\n<jats:p><jats:bold>Conclusions and Clinical Relevance<\/jats:bold>\u2014In healthy dogs, a moderate dose of azosemide caused sufficient diuretic action and increased PAC to a lesser extent than furosemide.<\/jats:p>","DOI":"10.2460\/ajvr.69.12.1664","type":"journal-article","created":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T13:50:38Z","timestamp":1228139438000},"page":"1664-1669","source":"Crossref","is-referenced-by-count":8,"title":["Assessment of diuretic effects and changes in plasma aldosterone concentration following oral administration of a single dose of furosemide or azosemide in healthy dogs"],"prefix":"10.2460","volume":"69","author":[{"given":"Yasutomo","family":"Hori","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Katou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mizuho","family":"Tsubaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazutaka","family":"Kanai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruriko","family":"Nakao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumio","family":"Hoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoyuki","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sei-ichi","family":"Higuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1272","reference":[{"key":"ref1","series-title":"Circulation","first-page":"e154","article-title":"ACC\/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"112","author":"Hunt","year":"2005"},{"key":"ref2","series-title":"Am J Vet Res","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.2460\/ajvr.68.10.1058","article-title":"Effects of oral administration of furosemide and torsemide in healthy dogs","volume":"68","author":"Hori","year":"2007"},{"key":"ref3","series-title":"J Am Soc Nephrol","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1681\/ASN.V1271335","article-title":"Loop diuretic infusion increases thiazide-sensitive Na(+)\/Cl(\u2212)-cotransporter abundance: role of aldosterone","volume":"12","author":"Abdallah","year":"2001"},{"key":"ref4","series-title":"Circulation","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1161\/01.CIR.0000124064.00494.21","article-title":"Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure","volume":"109","author":"Cataliotti","year":"2004"},{"key":"ref5","series-title":"Circulation","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1161\/hc0502.102962","article-title":"Differential actions of vasopeptidase inhibition versus angiotensin-converting enzyme inhibition on diuretic therapy in experimental congestive heart failure","volume":"105","author":"Cataliotti","year":"2002"},{"key":"ref6","series-title":"Nephrol Dial Transplant","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1093\/ndt\/gfg186","article-title":"Up-regulation of organic anion transporter 1 protein is induced by chronic furosemide or hydrochlorothiazide infusion in rat kidney","volume":"18","author":"Kim","year":"2003"},{"key":"ref7","series-title":"Am J Physiol Renal Physiol","doi-asserted-by":"publisher","first-page":"F133","DOI":"10.1152\/ajprenal.00227.2002","article-title":"Upregulation of Na+ transporter abundances in response to chronic thiazide or loop diuretic treatment in rats","volume":"284","author":"Na","year":"2003"},{"key":"ref8","series-title":"Eur J Heart Fail","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S1388-9842(00)00094-5","article-title":"Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure","volume":"2","author":"Paterna","year":"2000"},{"key":"ref9","series-title":"J Am Coll Cardiol","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/j.jacc.2004.04.059","article-title":"Furosemide and the progression of left ventricular dysfunction in experimental heart failure","volume":"44","author":"McCurley","year":"2004"},{"key":"ref10","series-title":"Clin Pharmacol Ther","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/clpt.1983.197","article-title":"Azosemide kinetics and dynamics","volume":"34","author":"Brater","year":"1983"},{"key":"ref11","series-title":"Clin Pharmacol Ther","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1002\/cpt1979254428","article-title":"Renal sites of action of azosemide","volume":"25","author":"Brater","year":"1979"},{"key":"ref12","series-title":"Drug Saf","doi-asserted-by":"publisher","first-page":"104","DOI":"10.2165\/00002018-199614020-00005","article-title":"Benefits and risks of torasemide in congestive heart failure and essential hypertension","volume":"14","author":"Brater","year":"1996"},{"key":"ref13","series-title":"Arzneimittelforschung","first-page":"346","article-title":"Renal actions of azosemide. 1. Clearance investigations in dogs","volume":"31","author":"Greven","year":"1981"},{"key":"ref14","series-title":"Am Heart J","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/S0002-8703(99)70504-1","article-title":"Effects of short-acting and long-acting loop diuretics on heart rate variability in patients with chronic compensated congestive heart failure","volume":"137","author":"Tomiyama","year":"1999"},{"key":"ref15","series-title":"Int J Clin Pharmacol Ther Toxicol","first-page":"10","article-title":"Phase 1 study of azosemide (SK-110): single- and multiple-dose study","volume":"21","author":"Kuzuya","year":"1983"},{"key":"ref16","series-title":"Biopharm Drug Dispos","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1002\/bdd.365","article-title":"Pharmacokinetics and pharmacodynamics of azosemide","volume":"24","author":"Suh","year":"2003"},{"key":"ref17","series-title":"Int J Clin Pharmacol Ther Toxicol","first-page":"532","article-title":"Comparison of azosemide and furosemide in ascitic patients without and during administration of spironolactone","volume":"20","author":"Rado","year":"1982"},{"key":"ref18","series-title":"J Cardiovasc Pharmacol","doi-asserted-by":"publisher","first-page":"S81","DOI":"10.1097\/00005344-200110001-00017","article-title":"Comparison of neurohumoral effects of short-acting and long-acting loop diuretics in patients with chronic congestive heart failure","volume":"38","author":"Tsutsui","year":"2001"},{"key":"ref19","series-title":"Cardiovasc Res","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.cardiores.2005.05.023","article-title":"Different effects of long- and short-acting loop diuretics on survival rate in Dahl high-salt heart failure model rats","volume":"68","author":"Yoshida","year":"2005"},{"key":"ref20","series-title":"J Vet Med Sci","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1292\/jvms.65.1057","article-title":"The effects of the loop diuretics furosemide and torasemide on diuresis in dogs and cats","volume":"65","author":"Uechi","year":"2003"},{"key":"ref21","series-title":"Kiso to Rinsho (Jpn)","first-page":"5233","article-title":"Behavior of azosemide (SK-110) in the body. A study on ADME of azosemide in rats, rabbits, dogs and monkeys","volume":"18","author":"Inoue","year":"1984"},{"key":"ref22","series-title":"Clin Pharmacokinet","doi-asserted-by":"publisher","first-page":"279","DOI":"10.2165\/00003088-197904040-00002","article-title":"Clinical pharmacokinetics of frusemide","volume":"4","author":"Cutler","year":"1979"},{"key":"ref23","series-title":"J Am Coll Cardiol","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/S0735-1097(03)00765-4","article-title":"Studies of left ventricular dysfunction. Diuretic use, progressive heart failure, and death in patients in the studies of left ventricular dysfunction (SOLVD)","volume":"42","author":"Domanski","year":"2003"},{"key":"ref24","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999"},{"key":"ref25","series-title":"Pharmacotherapy","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/j.1875-9114.1982.tb03188.x","article-title":"Pharmacology, therapeutic efficacy, and adverse effects of bumetanide, a new \u201cloop\u201d diuretic","volume":"2","author":"Flamenbaum","year":"1982"},{"key":"ref26","series-title":"Kiso to Rinsho (Jpn)","first-page":"5143","article-title":"A 26-week chronic toxicity study of azosemide (SK-110) in beagle dogs","volume":"18","author":"Tamano","year":"1984"},{"key":"ref27","series-title":"Eur J Pharmacol","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/0014-2999(81)90447-7","article-title":"The effect of renin and aldosterone inhibition by beta-adrenergic blockade on the response to the new diuretic azosemide","volume":"69","author":"Horky","year":"1981"}],"container-title":["American Journal of Veterinary Research"],"original-title":[],"link":[{"URL":"https:\/\/avmajournals.avma.org\/view\/journals\/ajvr\/69\/12\/ajvr.69.12.1664.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/avmajournals.avma.org\/downloadpdf\/journals\/ajvr\/69\/12\/ajvr.69.12.1664.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/avmajournals.avma.org\/downloadpdf\/journals\/ajvr\/69\/12\/ajvr.69.12.1664.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T12:47:03Z","timestamp":1741351623000},"score":1,"resource":{"primary":{"URL":"https:\/\/avmajournals.avma.org\/view\/journals\/ajvr\/69\/12\/ajvr.69.12.1664.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":27,"journal-issue":{"issue":"12"},"URL":"https:\/\/doi.org\/10.2460\/ajvr.69.12.1664","relation":{},"ISSN":["0002-9645"],"issn-type":[{"value":"0002-9645","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}